Table 3 Detection rates of CR-GNB in clinical and environmental samples from 2019 to 2022, n (%).
CR-GNB detection rate | 2019 | 2020 | 2021 | 2022 | Total |
|---|---|---|---|---|---|
Clinical | |||||
CR-GNB | 92/203 (45.3) | 83/215 (38.6) | 75/187 (40.1) | 155/293 (52.9) | 405/898 (45.1) |
CRAB | 63/68 (92.7) | 64/76 (84.2) | 46/53 (86.8) | 109/132 (82.6) | 282/329 (85.7) |
CRPA | 10/31 (32.3) | 15/37 (40.5) | 23/48 (47.9) | 17/52 (32.7) | 65/168 (38.7) |
CRKP | 19/104 (18.3) | 4/102 (3.9) | 6/86 (7.0) | 29/109 (26.6) | 58/401 (14.5) |
Environmental | |||||
CR-GNB | 5/18 (27.8) | 35/48 (72.9) | 22/31 (71.0) | 28/47 (59.6) | 90/144 (62.5) |
CRAB | 3/13 (23.1) | 25/32 (78.1) | 21/28 (75.0) | 23/35 (65.7) | 72/108 (66.7) |
CRPA | 1/2 (50.0) | 9/10 (90.0) | 0/1 (0) | 4/4 (100.0) | 14/17 (82.4) |
CRKP | 1/3 (33.3) | 1/6 (16.7) | 1/2 (50.0) | 1/8 (12.5) | 4/19 (21.1) |
